Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Upgrade Now
NasdaqGM - Nasdaq Real Time Price USD

Fractyl Health, Inc. (GUTS)

Compare
1.0700
-0.0500
(-4.46%)
At close: 4:00:02 PM EDT
1.1570
+0.09
+(8.13%)
After hours: 5:17:37 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
93
93
120
--
--
Cost of Revenue
50
50
77
--
--
Gross Profit
43
43
43
--
--
Operating Expense
93,574
93,574
50,879
49,385
36,928
Operating Income
-93,531
-93,531
-50,836
-49,385
-36,928
Net Non Operating Interest Income Expense
4,146
4,146
1,260
797
-1,442
Other Income Expense
20,691
20,691
-27,515
2,135
-365
Pretax Income
-68,694
-68,694
-77,091
-46,453
-38,735
Net Income Common Stockholders
-70,431
-70,431
-94,271
-63,633
-53,221
Diluted NI Available to Com Stockholders
-70,431
-70,431
-94,271
-63,633
-53,221
Basic EPS
-1.58
-1.62
-1.98
-1.34
-1.12
Diluted EPS
-1.58
-1.62
-1.98
-1.34
-1.12
Basic Average Shares
48,089.6250
43,541.5270
47,607.2010
47,607.2010
47,607.2010
Diluted Average Shares
48,089.6250
43,541.5270
47,607.2010
82,428.3630
47,607.2010
Total Operating Income as Reported
-93,531
-93,531
-50,836
-49,385
-36,928
Total Expenses
93,624
93,624
50,956
49,385
36,928
Net Income from Continuing & Discontinued Operation
-68,694
-68,694
-77,091
-46,453
-38,735
Normalized Income
-86,602
-86,602
-70,297
-46,277
-38,379
Interest Income
4,146
4,146
1,260
797
--
Interest Expense
--
--
--
--
1,442
Net Interest Income
4,146
4,146
1,260
797
-1,442
EBIT
-93,531
-93,531
-50,836
-49,385
-36,928
EBITDA
-92,854
-92,854
-50,550
-48,933
-36,252
Reconciled Cost of Revenue
50
50
77
--
--
Reconciled Depreciation
677
677
286
452
676
Net Income from Continuing Operation Net Minority Interest
-68,694
-68,694
-77,091
-46,453
-38,735
Total Unusual Items Excluding Goodwill
17,908
17,908
-6,794
-176
-356
Total Unusual Items
17,908
17,908
-6,794
-176
-356
Normalized EBITDA
-110,762
-110,762
-43,756
-48,757
-35,896
12/31/2021 - 2/2/2024

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

BCDA BioCardia, Inc.
1.9850
-1.24%
 
SYRE Spyre Therapeutics, Inc.
12.39
-3.13%
 
SNSE Sensei Biotherapeutics, Inc.
0.3000
+5.08%
 
ACXP Acurx Pharmaceuticals, Inc.
0.3282
+2.56%
 
FBLG FibroBiologics, Inc.
0.8699
-0.72%
 
ATXS Astria Therapeutics, Inc.
4.5000
-3.33%
 
CASI CASI Pharmaceuticals, Inc.
2.0100
-3.83%
 
GYRE Gyre Therapeutics, Inc.
7.62
+10.12%
 
KROS Keros Therapeutics, Inc.
9.98
0.00%
 
ANRO Alto Neuroscience, Inc.
2.2600
+25.56%